Endometrial Cancer Trial, Recruiting NCT05635123 Sponsor: Women's Hospital School Of Medicine Zhejiang University Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT05635123
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 20 and 75 years old
  • Women who have been newly and officially diagnosed with cervical cancer or endometrial cancer (confirmed by a tissue/pathology test) for the first time
  • Women who are attending a routine health check-up
  • People who are willing to give their consent and sign a consent form to take part

Who may not be able to join:

  • People with a mental health condition or cognitive difficulties that would make it hard to take part in the study's tests or assessments
  • People who have been diagnosed with a cancer other than cervical cancer or endometrial cancer
  • Women who have previously had their uterus surgically removed (hysterectomy) or who have had radiation therapy to the pelvic area in the past

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hui Wang, PhD, Women's Hospital School Of Medicine Zhejiang University

Phone: 0571-89998857

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Women's Hospital School Of Medicine Zhejiang University
Registry
ClinicalTrials.gov
Start date
15 September 2023
Est. completion
1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

progression free survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov